STAT-6 siRNA therapy (Roquefort Therapeutics)

N/A

Report date: 2025/01/26 18:07:02
NME

Base Information

Drug NameSTAT-6 siRNA therapy (Roquefort Therapeutics)
Drug Alias NameSTAT-6 Inhibitor (Roquefort Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSignal transducer and activator of transcription 6 inhibitors
TargetsSignal transducer and activator of transcription 6
Therapy Area/IndicationsSolid tumoursColonic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRoquefort Therapeutics plc
China Registration ClassN/A

Develop Information

Active CompaniesRoquefort Therapeutics plc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColonic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A